Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CASI Pharmaceuticals, Inc. - Ordinary Shares (NQ:CASI)

1.300 -0.130 (-9.09%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,174
Open 1.400
Bid (Size) 1.280 (10)
Ask (Size) 1.340 (2)
Prev. Close 1.430
Today's Range 1.300 - 1.415
52wk Range 1.091 - 7.670
Shares Outstanding 13,378,175
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga

Performance

YTD
-56.4%
-56.4%
1 Month
-2.3%
-2.3%
3 Month
-38.0%
-38.0%
6 Month
-50.9%
-50.9%
1 Year
-79.2%
-79.2%

More News

Read More
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill
CASI Pharmaceuticals Provides Business and Clinical Update
Via ACCESS Newswire
CASI Pharmaceuticals Announces First Quarter 2025 Business and Financial Results
Via ACCESS Newswire
CASI Pharmaceuticals Enters Into Definitive Agreement for the Divestiture of Assets in China
Via ACCESS Newswire
CASI Pharmaceuticals Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement
Via ACCESS Newswire
CASI Pharma Stock Rises On $20M Buyout Offer From CEO For China Business Operations: Retail Remains Extremely Bullish
Via Stocktwits
CASI Pharmaceuticals Announces Receipt of An Updated Non-Binding Proposal to Acquire Entire China Business of the Company
Via ACCESS Newswire
CASI Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Business and Financial Results
Via ACCESS Newswire
CASI Announces First Patient Dosed in Phase 1/2 Clinical Trial of CID-103 in Immune Thrombocytopenia
Via ACCESSWIRE
CASI Pharmaceuticals Announces Third Quarter 2024 Business and Financial Results
Via ACCESSWIRE
Earnings Scheduled For November 14, 2024
Via Benzinga
CASI Pharmaceuticals Receives CTA Approval From China's NMPA for CID-103 in Immune Thrombocytopenia
Via ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
CASI Stock Earnings: CASI Pharmaceuticals Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
3 Promising Biotech Stocks You Can Pick Up for Less Than $10
Via InvestorPlace
Week In Review: Fosun Pharma Plans $690 Million Deal To Privatize Henlius, Its Biologics Subsidiary
Via Talk Markets
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
CASI Stock Earnings: CASI Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
CASI Stock Earnings: CASI Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace

Frequently Asked Questions

Is CASI Pharmaceuticals, Inc. - Ordinary Shares publicly traded?
Yes, CASI Pharmaceuticals, Inc. - Ordinary Shares is publicly traded.
What exchange does CASI Pharmaceuticals, Inc. - Ordinary Shares trade on?
CASI Pharmaceuticals, Inc. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for CASI Pharmaceuticals, Inc. - Ordinary Shares?
The ticker symbol for CASI Pharmaceuticals, Inc. - Ordinary Shares is CASI on the Nasdaq Stock Market
What is the current price of CASI Pharmaceuticals, Inc. - Ordinary Shares?
The current price of CASI Pharmaceuticals, Inc. - Ordinary Shares is 1.300
When was CASI Pharmaceuticals, Inc. - Ordinary Shares last traded?
The last trade of CASI Pharmaceuticals, Inc. - Ordinary Shares was at 07/15/25 04:00 PM ET
What is the market capitalization of CASI Pharmaceuticals, Inc. - Ordinary Shares?
The market capitalization of CASI Pharmaceuticals, Inc. - Ordinary Shares is 17.39M
How many shares of CASI Pharmaceuticals, Inc. - Ordinary Shares are outstanding?
CASI Pharmaceuticals, Inc. - Ordinary Shares has 17M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.